TIMP3 and arthritic joint disease: Ablation of TIMP-3 in mouse, and subsequent loss of ADAM17 inhibition, leads to arthritis, chronic hepatic inflammation, insulin resistance, and liver/heart failure due to excessive release of tumor necrosis factor (TNF) [5,6,7].